Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LIPTON

Showing results (1081-1090 of 1,306) with videos related to

Pageof 131
Sort By:
Cephalalgia : an International Journal of Headache|December 9, 2024
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trialsChristopher Gottschalk, Pranav Gandhi, Patricia Pozo-Rosich, et al.
Journal of Psychosomatic Research|September 10, 2023
Older adults' self-reported prospective memory lapses in everyday life: Connections to inflammation and genderErin E Harrington, Jennifer E Graham-Engeland, Martin J Sliwinski, et al.
The Journal of Headache and Pain|February 8, 2022
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF studyPeter McAllister, Paul K Winner, Jessica Ailani, et al.
The Journal of Headache and Pain|July 14, 2010
Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS courseIlya Kister, A B Caminero, T S Monteith, et al.
The Journal of Headache and Pain|August 19, 2024
Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) studyMichel Lanteri-Minet, Elizabeth Leroux, Zaza Katsarava, et al.
Annals of Emergency Medicine|January 11, 2007
Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentationBenjamin W Friedman, Michael L Hochberg, David Esses, et al.
Headache|February 20, 2020
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and IIDavid W Dodick, Richard B Lipton, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|November 26, 2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implicationsPeter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsAngel Garcia De La Garza, Carol A Derby, Qi Gao, et al.
Headache|October 4, 2025
Navigating the patient journey in migraine prevention: An American Migraine Foundation position paperLawrence C Newman, Christine Lay, Richard B Lipton, et al.
Pageof 131

Showing results (1081-1090 of 1,306) with videos related to

Sort By:
Pageof 131
Cephalalgia : an International Journal of Headache|December 9, 2024
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trialsChristopher Gottschalk, Pranav Gandhi, Patricia Pozo-Rosich, et al.
Journal of Psychosomatic Research|September 10, 2023
Older adults' self-reported prospective memory lapses in everyday life: Connections to inflammation and genderErin E Harrington, Jennifer E Graham-Engeland, Martin J Sliwinski, et al.
The Journal of Headache and Pain|February 8, 2022
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF studyPeter McAllister, Paul K Winner, Jessica Ailani, et al.
The Journal of Headache and Pain|July 14, 2010
Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS courseIlya Kister, A B Caminero, T S Monteith, et al.
The Journal of Headache and Pain|August 19, 2024
Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) studyMichel Lanteri-Minet, Elizabeth Leroux, Zaza Katsarava, et al.
Annals of Emergency Medicine|January 11, 2007
Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentationBenjamin W Friedman, Michael L Hochberg, David Esses, et al.
Headache|February 20, 2020
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and IIDavid W Dodick, Richard B Lipton, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|November 26, 2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implicationsPeter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsAngel Garcia De La Garza, Carol A Derby, Qi Gao, et al.
Headache|October 4, 2025
Navigating the patient journey in migraine prevention: An American Migraine Foundation position paperLawrence C Newman, Christine Lay, Richard B Lipton, et al.
Pageof 131